Inhibitor Therapeutics, Inc. (INTI) Operating income 2016–2025
Inhibitor Therapeutics, Inc. (INTI) annual operating income history from SEC filings — each fiscal year as reported.
-$3.4MFY2025 · since FY2016: -$7.0M → -$3.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.4M | +6.3% |
| FY2024 | -$3.7M | -7.4% |
| FY2023 | -$3.4M | -417.5% |
| FY2022 | -$657,926 | -102.2% |
| FY2021 | -$325,395 | +69.3% |
| FY2020 | -$1.1M | +61.5% |
| FY2019 | -$2.7M | +39.8% |
| FY2018 | -$4.6M | +10.8% |
| FY2017 | -$5.1M | +27.1% |
| FY2016 | -$7.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice